2-indazol-2-yl-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;2-(3-methyl-2H-benzimidazol-2-id-1-yl)-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;platinum;tris(platinum(2+));2-pyrazol-1-yl-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-2-(triazol-1-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide
C144H98N21Pt4-3 — CID 158897163
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-indazol-2-yl-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;2-(3-methyl-2H-benzimidazol-2-id-1-yl)-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;platinum;tris(platinum(2+));2-pyrazol-1-yl-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-2-(triazol-1-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide
2-indazol-2-yl-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;2-(3-methyl-2H-benzimidazol-2-id-1-yl)-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;platinum;tris(platinum(2+));2-pyrazol-1-yl-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-2-(triazol-1-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide (PubChem CID 158897163) has the molecular formula C144H98N21Pt4-3 and a molecular weight of 2902.83 g/mol. Its IUPAC name is 2-indazol-2-yl-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;2-(3-methyl-2H-benzimidazol-2-id-1-yl)-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;platinum;tris(platinum(2+));2-pyrazol-1-yl-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-2-(triazol-1-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide.
Molecular Properties
| Compound Name | 2-indazol-2-yl-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;2-(3-methyl-2H-benzimidazol-2-id-1-yl)-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;platinum;tris(platinum(2+));2-pyrazol-1-yl-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-2-(triazol-1-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide |
|---|---|
| PubChem CID | 158897163 |
| Molecular Formula | C144H98N21Pt4-3 |
| Molecular Weight | 2902.83 g/mol |
| Exact Mass | 2900.69 |
| IUPAC Name | 2-indazol-2-yl-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;2-(3-methyl-2H-benzimidazol-2-id-1-yl)-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;platinum;tris(platinum(2+));2-pyrazol-1-yl-11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide;11-(9-pyridin-2-yl-1H-carbazol-1-id-2-yl)-2-(triazol-1-yl)-5,6-dihydro-1H-benzo[b][1]benzazepin-1-ide |
| SMILES | CN1[CH-]N(c2[c-]c3c(cc2)CCc2ccccc2N3c2[c-]c3c(cc2)c2ccccc2n3-c2ccccn2)c2ccccc21.[Pt+2].[Pt+2].[Pt+2].[Pt].[c-]1c(-n2cc3ccccc3n2)ccc2c1N(c1[c-]c3c(cc1)c1ccccc1n3-c1ccccn1)c1ccccc1CC2.[c-]1c(-n2cccn2)ccc2c1N(c1[c-]c3c(cc1)c1ccccc1n3-c1ccccn1)c1ccccc1CC2.[c-]1c(-n2ccnn2)ccc2c1N(c1[c-]c3c(cc1)c1ccccc1n3-c1ccccn1)c1ccccc1CC2 |
| InChI | InChI=1S/C39H28N5.C38H25N5.C34H23N5.C33H22N6.4Pt/c1-41-26-42(36-15-7-6-14-35(36)41)29-20-19-28-18-17-27-10-2-4-12-33(27)43(37(28)24-29)30-21-22-32-31-11-3-5-13-34(31)44(38(32)25-30)39-16-8-9-23-40-39;1-4-12-33-28(10-1)25-41(40-33)29-19-18-27-17-16-26-9-2-5-13-34(26)42(36(27)23-29)30-20-21-32-31-11-3-6-14-35(31)43(37(32)24-30)38-15-7-8-22-39-38;1-3-10-30-24(8-1)13-14-25-15-16-26(37-21-7-20-36-37)22-32(25)38(30)27-17-18-29-28-9-2-4-11-31(28)39(33(29)23-27)34-12-5-6-19-35-34;1-3-9-29-23(7-1)12-13-24-14-15-25(37-20-19-35-36-37)21-31(24)38(29)26-16-17-28-27-8-2-4-10-30(27)39(32(28)22-26)33-11-5-6-18-34-33;;;;/h2-16,19-23,26H,17-18H2,1H3;1-15,18-22,25H,16-17H2;1-12,15-21H,13-14H2;1-11,14-20H,12-13H2;;;;/q-3;3*-2;;3*+2 |
| InChIKey | ASTNITANNRPDRV-UHFFFAOYSA-N |
| XLogP | 32.19 |
| TPSA | 157.07 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 169 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2902.83 |
| LogP ≤ 5 | 32.19 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 21 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158897163 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.